We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.

PerkinElmer and IDBS Announce Software Collaboration for Drug Discovery Research

PerkinElmer and IDBS Announce Software Collaboration for Drug Discovery Research

PerkinElmer and IDBS Announce Software Collaboration for Drug Discovery Research

PerkinElmer and IDBS Announce Software Collaboration for Drug Discovery Research

Read time:

Want a FREE PDF version of This News Story?

Complete the form below and we will email you a PDF version of "PerkinElmer and IDBS Announce Software Collaboration for Drug Discovery Research"

First Name*
Last Name*
Email Address*
Company Type*
Job Function*
Would you like to receive further email communication from Technology Networks?

Technology Networks Ltd. needs the contact information you provide to us to contact you about our products and services. You may unsubscribe from these communications at any time. For information on how to unsubscribe, as well as our privacy practices and commitment to protecting your privacy, check out our Privacy Policy

IDBS has announced a collaboration with PerkinElmer, Inc. at the 6th Annual High Content Analysis Conference in San Francisco.

The collaboration will be focused on improving data analysis and interpretation of High Content Screening (HCS), an enabling technology in the search for key cellular markers associated with human health and disease.

The collaboration features the integration of PerkinElmer’s Columbus™ image data management system for HCS with IDBS’s ActivityBase XE screening data management software.

The collaboration will provide researchers with a unified interface to access both Columbus’s image data storage capabilities and ActivityBase XE’s screening data analysis and interpretation features, to enable compelling exploratory outcomes in HCS and cellular analysis.

“The future of High Content Screening lies in an increased synergy between technologies that integrate vast image content with large compound sets, to generate actionable research data,” said Richard M. Eglen, Ph.D., president, Bio-discovery, PerkinElmer. “We feel this collaboration with IDBS is a timely and highly promising advance in giving researchers access to greater insights into the cell-based mechanisms of disease, as well as development of novel therapies based on greater understanding of the origins of diseases.”

Neil Kipling, CEO of IDBS, said “ActivityBase XE maintains IDBS’s leading position in data management for the global drug discovery industry, offering innovation and scalable functionality to screening groups worldwide. This new relationship with PerkinElmer provides scientists with the high performance data management tools necessary to maximize the promise which this technical innovation presents.”

PerkinElmer’s Columbus software is a flexible solution for high volume image storage and management. Designed as a partner product for the Opera™ system, PerkinElmer's confocal microplate imaging reader, the software has the added benefit of full compatibility with a wide range of image file formats.

IDBS’s ActivityBase XE delivers ultra high performance data analysis, flexible data visualization/interpretation and storage in one working environment. The new features in ActivityBase XE enable users to analyze rich, multivariant data, perform curve fitting and complex statistics within each well of a MTS, HTS or uHTS experiment.